BeOne Medicines
ONC
#649
Rank
S$46.32 B
Marketcap
S$418.66
Share price
-2.56%
Change (1 day)
50.35%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$4.54 Billion

According to BeOne Medicines's latest financial reports the company's total liabilities are S$4.54 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BeOne Medicines - Total liabilities on balance sheet (from 2014 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$3.51 B17.48%
2023-12-31S$2.99 B11.94%
2022-12-31S$2.67 B-17.63%
2021-12-31S$3.24 B41.82%
2020-12-31S$2.29 B168.02%
2019-12-31S$0.85 B26.12%
2018-12-31S$0.67 B39.87%
2017-12-31S$0.48 B532.76%
2016-12-31S$76.57 M27.53%
2015-12-31S$60.03 M63.14%
2014-12-31S$36.8 M-42.51%
2013-12-31S$64.01 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Onconova Therapeutics
ONTX
S$15.76 M-99.65%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
S$0.89 B-80.30%๐Ÿ‡บ๐Ÿ‡ธ USA